Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • l40characters l40characters Oct 29, 2013 7:02 AM Flag

    Arikace small revenues in Europe expected if Approval is given in 2015

    Sales of Novartis podhaler are exploding in the USA and in Europe.Price and convience over Arikace
    Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation. "Managing daily CF treatments is a challenge for people with CF. TOBI Podhaler helps relieve that burden by shortening the time it takes to administer the medicine and making it easy for people with CF to take their treatment with them wherever they need to go

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
24.42+0.97(+4.14%)Jun 30 4:00 PMEDT